NCT06307574 · RECRUITING
bpMedManage: Digital Technology to Support Adherence to Hypertension Medications
This trial is testing a smartphone app designed to help older adults with mild cognitive impairment stick to their blood pressure medications. One group gets the app with reminders plus education; the other gets education alone. Researchers are measuring whether the reminders improve adherence over 16 weeks. This is a Phase NA randomized controlled trial — it is evaluating effectiveness of a behavioral tool, not a drug or medical device requiring phased approval.
You may qualify if
- Age 60+
- Community-dwelling older adults
- Self-reported fluent in English
- Adequate self-reported visual and hearing ability
- Self-reported memory, thinking, or concentration challenges
- Self-manage at least one prescribed antihypertensive medication
- Have and use a smartphone
- No self-reported history of major depression or other mental health diagnoses
- No self-reported diagnosis of dementia or other neurological disorder such as stroke, TBI, and Parkinson's disease
- TICS-M score between 27-37 and Montreal Cognitive Assessment (MoCA) score between 20-26
- Willing to participate in the study for at least 4 months
You're excluded if
- Diagnosis of dementia
- Lives in assisted living facility or skilled nursing facility
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-10-15